Timothy Pearson
Vorsitzender bei GLYCOMIMETICS, INC.
Vermögen: 42 152 $ am 30.04.2024
Aktive Positionen von Timothy Pearson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GLYCOMIMETICS, INC. | Independent Dir/Board Member | 31.03.2014 | - |
Vorsitzender | 17.05.2019 | - | |
Direktor/Vorstandsmitglied | 31.03.2014 | 17.05.2019 | |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | Vorstandsvorsitzender | 01.06.2019 | - |
Carrick Therapeutics UK Ltd.
Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Vorstandsvorsitzender | 01.07.2019 | - |
Karriereverlauf von Timothy Pearson
Ehemalige bekannte Positionen von Timothy Pearson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
RA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.05.2016 | 02.04.2020 |
Independent Dir/Board Member | 01.05.2016 | 02.04.2020 | |
TESARO INC | Comptroller/Controller/Auditor | 25.11.2017 | 01.02.2019 |
Finanzdirektor/CFO | 25.05.2014 | 01.02.2019 | |
Catalyst Health Solutions, Inc.
Catalyst Health Solutions, Inc. Internet Software/ServicesTechnology Services Catalyst Health Solutions, Inc. was provided pharmacy benefit management services. The company was founded in 1999 and was headquartered in Rockville, MD. | Finanzdirektor/CFO | 22.08.2011 | 02.07.2012 |
Public Communications Contact | 22.08.2011 | 02.07.2012 | |
Treasurer | 22.08.2011 | 02.07.2012 | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Finanzdirektor/CFO | 01.09.1998 | 01.08.2011 |
CIGNA Insurance Co. of North America (UK) Ltd. | Corporate Officer/Principal | - | - |
XENCOR, INC. | Direktor/Vorstandsmitglied | 29.11.2010 | - |
░░░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Timothy Pearson
University of Delaware | Undergraduate Degree |
Loyola University Maryland, Inc. | Graduate Degree |
University of Maryland University College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 12 |
Vereinigtes Königreich | 3 |
Irland | 2 |
Operativ
Director/Board Member | 4 |
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
XENCOR, INC. | Health Technology |
GLYCOMIMETICS, INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Allfirst Bank (Baltimore, Maryland) | Finance |
Integrated Health Services, Inc.
Integrated Health Services, Inc. Hospital/Nursing ManagementHealth Services Integrated Health Services, Inc. provides post-acute healthcare services. Its Post-acute care is the provision of a continuum of care to patients following discharge from an acute care hospital. Its post-acute care services and products include inpatient services, home respiratory care & durable medical equipment, diagnostic services and lithotripsy which is a non-invasive technique that uses shockwaves to disintegrate kidney stones primarily on an outpatient basis. The company's post-acute care network is designed to address the cost containment measures implemented by private insurers & managed care organizations and limitations on government reimbursement of hospital costs that have resulted in the discharge from hospitals of many patients who continue to require medical and rehabilitative care. | Health Services |
CIGNA Insurance Co. of North America (UK) Ltd. | |
Catalyst Health Solutions, Inc.
Catalyst Health Solutions, Inc. Internet Software/ServicesTechnology Services Catalyst Health Solutions, Inc. was provided pharmacy benefit management services. The company was founded in 1999 and was headquartered in Rockville, MD. | Technology Services |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | Health Technology |
Carrick Therapeutics UK Ltd.
Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Commercial Services |
- Börse
- Insiders
- Timothy Pearson
- Erfahrung